Division of Neurosurgery, University of Vermont, Burlington, Vermont, USA.
World Neurosurg. 2013 Dec;80(6):889-92. doi: 10.1016/j.wneu.2012.06.026. Epub 2012 Jun 19.
To propose that chronic subdural hematoma (CSDH) should be conceived as a sentinel event in elderly patients and offer an analysis of long-term survival after diagnosis.
A retrospective review of 301 consecutive patients ≥55 years old admitted to an academic medical center with a primary diagnosis of CSDH between January 1996 and January 2010 was performed. The effects of advanced age and surgical intervention on survival were independently assessed. These groups were compared with standardized mortality ratios (SMRs) on the basis of patient age at time of presentation.
Mortality after diagnosis of CSDH increases with increased age at presentation. For all patients, the median survival was roughly 4 years after diagnosis (4.0 years ± 0.5). Median survival is decreased with older age at presentation, to a nadir of 1.5 years ± 0.6 for patients ≥85 years old (P = 0.0003, log-rank test). Compared with the reference data from the U.S. Centers of Disease Control and Prevention, 1-year SMR was increased in all age groups. An asymmetric increase in SMR was seen between age groups, with the greatest effect on the youngest subpopulation (SMR 2.9).
The increased mortality rates in patients with CSDHs relative to standardized mortality data corroborate the conception of subdural hematoma as a sentinel health event.
提出慢性硬脑膜下血肿(CSDH)应被视为老年患者的一个预警事件,并对诊断后的长期生存情况进行分析。
回顾性分析了 1996 年 1 月至 2010 年 1 月期间在一家学术医疗中心因原发性 CSDH 住院的 301 例年龄≥55 岁的连续患者。分别评估了高龄和手术干预对生存的影响。根据患者就诊时的年龄,将这些组与标准化死亡率(SMR)进行比较。
CSDH 诊断后的死亡率随就诊时年龄的增加而增加。所有患者的中位生存时间约为诊断后 4 年(4.0 年±0.5 年)。中位生存时间随就诊年龄的增加而降低,≥85 岁患者的中位生存时间降至 1.5 年±0.6 年(P=0.0003,对数秩检验)。与美国疾病控制与预防中心的参考数据相比,所有年龄组的 1 年 SMR 均升高。年龄组之间 SMR 呈不对称性增加,对最年轻的亚群影响最大(SMR 2.9)。
CSDH 患者的死亡率相对于标准化死亡率数据的升高,证实了硬脑膜下血肿作为一个预警健康事件的概念。